![Dov Elefant](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dov Elefant
Financieel Directeur/CFO bij
FEMASYS INC.
Vermogen: 12 214 $ op 30-06-2026
Profiel
Dov S.
Elefant currently works at Femasys, Inc., as Chief Financial Officer from 2022.
Mr. Elefant also formerly worked at Tetragenex Pharmaceuticals, Inc., as Director-Accounting & Finance from 1999 to 2007, Synvista Therapeutics, Inc., as Assistant Controller from 1998 to 1999, Celsus Therapeutics Plc, as Chief Operating & Financial Officer from 2013 to 2015, Althera Medical Ltd., as Chief Financial Officer, Lev Pharmaceuticals, Inc., as Controller from 2007 to 2009, EpiCept Corp., as Controller, VP-Finance & Administration from 1999 to 2007, Cellectar Biosciences, Inc., as Chief Financial Officer & Vice President from 2019 to 2022, and Akari Therapeutics Plc, as Chief Financial Officer from 2012 to 2019.
Mr. Elefant received his undergraduate degree from Sy Syms School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
FEMASYS, INC. 0,1% | 15-04-2026 | 2.922 ( 0,1% ) | 12 214 $ | 30-06-2026 |
Actieve functies van Dov Elefant
| Bedrijven | Functie | Begin |
|---|---|---|
| FEMASYS INC. | Financieel Directeur/CFO | 28-02-2022 |
Eerdere bekende functies van Dov Elefant
| Bedrijven | Functie | Einde |
|---|---|---|
| CELLECTAR BIOSCIENCES, INC. | Financieel Directeur/CFO | 23-02-2022 |
| AKARI THERAPEUTICS, PLC | Financieel Directeur/CFO | 15-09-2019 |
Althera Medical Ltd.
 Althera Medical Ltd. Medical SpecialtiesHealth Technology Develops therapeutic devices for the treatment of various cancers | Financieel Directeur/CFO | - |
Lev Pharmaceuticals, Inc.
 Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutic products for the treatment of inflammatory diseases | Comptroller/Controller/Auditor | 01-02-2009 |
EpiCept Corp.
 EpiCept Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer and pain | Financieel Directeur/CFO | 01-03-2007 |
Opleiding van Dov Elefant
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
62
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Synvista Therapeutics, Inc.
 Synvista Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for diseases of cardiovascular aging and diabetes complications | Health Technology |
Celsus Therapeutics Plc
 Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops novel non steroidal anti-inflammatory drugs | Health Technology |
Femasys, Inc.
 Femasys, Inc. Electronic Equipment/InstrumentsElectronic Technology Operates as a medical device company that focuses on women''s healthcare | Electronic Technology |
Tetragenex Pharmaceuticals, Inc.
 Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and commercializes antibiotics | Health Technology |
Althera Medical Ltd.
Althera Medical Ltd. Medical SpecialtiesHealth Technology Develops therapeutic devices for the treatment of various cancers | Health Technology |
Lev Pharmaceuticals, Inc.
Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutic products for the treatment of inflammatory diseases | Health Technology |
EpiCept Corp.
EpiCept Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer and pain | Health Technology |
Cellectar Biosciences, Inc.
 Cellectar Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that is engaged in developing compounds for the treatment and imaging of cancer | Health Technology |
Sy Syms School of Business
 Sy Syms School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akari Therapeutics Plc
 Akari Therapeutics Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapies for autoimmune and inflammatory diseases | Health Technology |
